CLINICAL RESEARCH: HEART FAILURE
The Right Ventricular Failure Risk ScoreA Pre-Operative Tool for Assessing the Risk of Right Ventricular Failure in Left Ventricular Assist Device Candidates
Jennifer Cowger Matthews, MD*,
Todd M. Koelling, MD*,
Francis D. Pagani, MD, PhD and
Keith D. Aaronson, MD, MS*,*
* Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, Michigan
Section of Cardiac Surgery, University of Michigan Health System, Ann Arbor, Michigan.
Manuscript received August 20, 2007;
revised manuscript received February 7, 2008,
accepted March 4, 2008.
* Reprint requests and correspondence: Dr. Keith D. Aaronson, University of Michigan Cardiovascular Center, Room 2169, 1500 East Medical Center Drive, SPC 5853, Ann Arbor, Michigan 48109-5853. (Email: keith{at}med.umich.edu).
Objectives: This study sought to develop a model that estimates the post-operative risk of right ventricular (RV) failure in left ventricular assist device (LVAD) candidates.
Background: Right ventricular failure after LVAD surgery is associated with increased morbidity and mortality, but identifying LVAD candidates at risk for RV failure remains difficult.
Methods: A prospectively collected LVAD database was evaluated for pre-operative clinical, laboratory, echocardiographic, and hemodynamic predictors of RV failure. Right ventricular failure was defined as the need for post-operative intravenous inotrope support for >14 days, inhaled nitric oxide for 48 h, right-sided circulatory support, or hospital discharge on an inotrope. An RV failure risk score (RVFRS) was created from multivariable logistic regression model coefficients, and a receiver-operating characteristic curve of the score was generated.
Results: Of 197 LVADs implanted, 68 (35%) were complicated by post-operative RV failure. A vasopressor requirement (4 points), aspartate aminotransferase 80 IU/l (2 points), bilirubin 2.0 mg/dl (2.5 points), and creatinine 2.3 mg/dl (3 points) were independent predictors of RV failure. The odds ratio for RV failure for patients with an RVFRS 3.0, 4.0 to 5.0, and 5.5 were 0.49 (95% confidence interval [CI] 0.37 to 0.64), 2.8 (95% CI 1.4 to 5.9), and 7.6 (95% CI 3.4 to 17.1), respectively, and 180-day survivals were 90 ± 3%, 80 ± 8%, and 66 ± 9%, respectively (log rank for linear trend p = 0.0045). The area under the receiver-operating characteristic curve for the RVFRS (0.73 ± 0.04) was superior to that of other commonly used predictors of RV failure (all p < 0.05).
Conclusions: The RVFRS, composed of routinely collected, noninvasive pre-operative clinical data, effectively stratifies the risk of RV failure and death after LVAD implantation.
|
Abbreviations and Acronyms
| | AST = aspartate aminotransferase | | AUC = area under the curve | | CI = confidence interval | | ECMO = extracorporeal membrane oxygenation | | iNO = inhaled nitric oxide | | LV = left ventricle/ventricular | | LVAD = left ventricular assist device | | OR = odds ratio | | PA = pulmonary artery | | PVR = pulmonary vascular resistance | | RA = right atrial | | RV = right ventricle/ventricular | | RVAD = right ventricular assist device | | RVFRS = right ventricular failure risk score(s) | | RVSWI = right ventricular stroke work index |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A29-A30.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
F. D. Pagani, L. W. Miller, S. D. Russell, K. D. Aaronson, R. John, A. J. Boyle, J. V. Conte, R. C. Bogaev, T. E. MacGillivray, Y. Naka, et al.
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
J. Am. Coll. Cardiol.,
July 21, 2009;
54(4):
312 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Eisen and S. R. Hankins
Continuous flow rotary left ventricular assist device: mechanical circulatory support 2.0.
J. Am. Coll. Cardiol.,
July 21, 2009;
54(4):
322 - 324.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Wilson, G. H. Mudge Jr, G. C. Stewart, and M. M. Givertz
Evaluation for a Ventricular Assist Device: Selecting the Appropriate Candidate
Circulation,
April 28, 2009;
119(16):
2225 - 2232.
[Full Text]
[PDF]
|
 |
|
|